首页 > 最新文献

Canadian liver journal最新文献

英文 中文
The feasibility and acceptability of an online mind-body wellness program for patients with primary biliary cholangitis 原发性胆管炎患者在线身心健康项目的可行性和可接受性
Pub Date : 2023-11-03 DOI: 10.3138/canlivj-2022-0045
Makayla Watt, Ashley Hyde, John C Spence, Gail M Wright, Shauna Vander Well, Emily Johnson, Andrew Mason, Magnus McLeod, Puneeta Tandon
Background: Persons with primary biliary cholangitis (PBC) experience significantly higher rates of mental distress and impaired health related quality of life (HrQoL) than the general population. Given limited evidence, but a high need, our primary aim was to assess feasibility and acceptability of a 12-week, online, mind–body wellness program in people with PBC. Methods: This was a single-group, sequential mixed-methods, pre-post feasibility, and acceptability study. Core program components included follow-along movement, meditation and breathwork videos, and cognitive behavioural therapy informed activities. This was supplemented by weekly phone check-ins. Feasibility was assessed by recruitment, adherence, and retention. The pre-post exploratory efficacy assessment included surveys for fatigue, perceived stress, anxiety, depression, HrQoL, and resilience. A qualitative descriptive approach with semi-structured interviews evaluated study experiences. Results: Thirty-two participants were recruited within 30 days and 29 (91%) were retained to end-of-study. Of these, 25 (86%) adhered to carrying out the mind–body practice at least 2–3 days per week. Feedback supported acceptability (satisfaction score 90%). Significant improvements were observed in fatigue (13%, p = 0.004), anxiety (30%, p = 0.005), depression (28%, p = 0.004), and five PBC-40 domains (itch, fatigue, cognitive, emotional, general symptoms). Qualitative interviews revealed improved stress management, better coping, and a more positive mindset. Fatigue and self-sabotaging thoughts were cited as barriers to participation. Conclusions: These findings suggest that a 12-week online mind–body intervention is feasible and acceptable in patients with PBC. After iterative refinement, a randomized controlled trial will be designed using this feedback.
背景:原发性胆管炎(PBC)患者的精神困扰和健康相关生活质量(HrQoL)受损率明显高于一般人群。鉴于证据有限,但需求很高,我们的主要目的是评估PBC患者12周在线身心健康计划的可行性和可接受性。方法:采用单组、顺序混合方法、前后可行性和可接受性研究。核心项目包括后续运动、冥想和呼吸视频,以及认知行为疗法相关活动。除此之外,每周还会有电话检查。可行性通过招募、依从性和保留进行评估。前后探索性疗效评估包括疲劳、感知压力、焦虑、抑郁、HrQoL和恢复力的调查。采用半结构化访谈的定性描述方法评估研究经验。结果:32名参与者在30天内被招募,29名(91%)被保留到研究结束。其中,25人(86%)坚持每周至少进行2-3天的身心练习。反馈支持可接受性(满意度评分90%)。在疲劳(13%,p = 0.004)、焦虑(30%,p = 0.005)、抑郁(28%,p = 0.004)和5个PBC-40领域(瘙痒、疲劳、认知、情绪、一般症状)方面观察到显著改善。定性访谈显示,他们的压力管理、应对能力和心态都有所改善。疲劳和自我破坏的想法被认为是参与的障碍。结论:这些发现表明,对PBC患者进行为期12周的在线身心干预是可行和可接受的。经过反复的改进,将利用这些反馈设计一个随机对照试验。
{"title":"The feasibility and acceptability of an online mind-body wellness program for patients with primary biliary cholangitis","authors":"Makayla Watt, Ashley Hyde, John C Spence, Gail M Wright, Shauna Vander Well, Emily Johnson, Andrew Mason, Magnus McLeod, Puneeta Tandon","doi":"10.3138/canlivj-2022-0045","DOIUrl":"https://doi.org/10.3138/canlivj-2022-0045","url":null,"abstract":"Background: Persons with primary biliary cholangitis (PBC) experience significantly higher rates of mental distress and impaired health related quality of life (HrQoL) than the general population. Given limited evidence, but a high need, our primary aim was to assess feasibility and acceptability of a 12-week, online, mind–body wellness program in people with PBC. Methods: This was a single-group, sequential mixed-methods, pre-post feasibility, and acceptability study. Core program components included follow-along movement, meditation and breathwork videos, and cognitive behavioural therapy informed activities. This was supplemented by weekly phone check-ins. Feasibility was assessed by recruitment, adherence, and retention. The pre-post exploratory efficacy assessment included surveys for fatigue, perceived stress, anxiety, depression, HrQoL, and resilience. A qualitative descriptive approach with semi-structured interviews evaluated study experiences. Results: Thirty-two participants were recruited within 30 days and 29 (91%) were retained to end-of-study. Of these, 25 (86%) adhered to carrying out the mind–body practice at least 2–3 days per week. Feedback supported acceptability (satisfaction score 90%). Significant improvements were observed in fatigue (13%, p = 0.004), anxiety (30%, p = 0.005), depression (28%, p = 0.004), and five PBC-40 domains (itch, fatigue, cognitive, emotional, general symptoms). Qualitative interviews revealed improved stress management, better coping, and a more positive mindset. Fatigue and self-sabotaging thoughts were cited as barriers to participation. Conclusions: These findings suggest that a 12-week online mind–body intervention is feasible and acceptable in patients with PBC. After iterative refinement, a randomized controlled trial will be designed using this feedback.","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":"233 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135775125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The benefits of a team approach to cirrhosis care 团队治疗肝硬化的益处
Pub Date : 2023-11-03 DOI: 10.3138/canlivj-2023-0017
Puja Chauhan, Natasha Chandok
{"title":"The benefits of a team approach to cirrhosis care","authors":"Puja Chauhan, Natasha Chandok","doi":"10.3138/canlivj-2023-0017","DOIUrl":"https://doi.org/10.3138/canlivj-2023-0017","url":null,"abstract":"","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":"33 35","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135819136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geographical disparities in gastroenterologists and transient elastography across Canada 加拿大胃肠病学家和瞬态弹性成像的地理差异
Pub Date : 2023-10-19 DOI: 10.3138/canlivj-2023-0010
Jessica Burnside, Tyler Thomas, Giada Sebastiani, Sahar Saeed
Background: In the next decade, the incidence and prevalence of advanced liver disease are expected to increase across Canada. However, little is known about the country's resources for monitoring patients requiring specialized care. A resource assessment was conducted to evaluate regional disparities of specialists and transient elastography machines across Canada. Methods: Demographic data on licenced gastroenterologists were obtained from Scott's Medical Directory as of October 2022. The primary location of each specialist was linked to 2016 Statistics Canada to obtain the population size and density of province/territories and census division (CD). Results were summarized per 100,000 persons. CD were classified as resource scare or approaching resource scarcity. A list of transient elastography (TE) was provided by KNS Canada Inc. and summarized per 1,000,000 persons by province. Results: Eight hundred fifty-three specialists were identified. Rates of gastroenterologists per 100,000 people ranged from 0 in the territories to 2.9 in Quebec. Half the provinces had less than 2.0 gastroenterologists per 100,000 persons. Gastroenterologists were concentrated in 24% (71/293) of the CDs across Canada. We identified resource-scarce CDs as areas with no gastroenterologists and in the highest tercile of population density, which accounted for 33% (1 of 3) in Prince Edward Island, 32% in Quebec, 25% in Ontario, 7% in British Columbia, and 4% in Manitoba. Only 94 TEs were identified nationwide. Conclusion: We found significant variation in liver-specific resources across Canada. Given the increasing number of people living with liver disease, policies must be implemented to address access to specialized care.
背景:在未来十年,预计加拿大晚期肝病的发病率和患病率将增加。然而,人们对该国用于监测需要专门护理的患者的资源知之甚少。资源评估进行了评估专家和瞬态弹性成像机在加拿大各地的区域差异。方法:截至2022年10月,从Scott's Medical Directory获得有执照的胃肠病学家的人口统计数据。每个专家的主要位置与2016年加拿大统计局相关联,以获得省/地区和人口普查局(CD)的人口规模和密度。结果汇总每10万人。CD被归类为资源稀缺或接近资源稀缺。KNS加拿大公司提供了一份瞬态弹性图(TE)列表,并按省份汇总了每100万人的数据。结果:共鉴定专家853人。每10万人中胃肠病学家的比率从领地的0到魁北克的2.9不等。一半的省份每10万人中有不到2.0名胃肠病学家。胃肠病学家集中在加拿大24%(71/293)的cd中。我们将资源稀缺的cd确定为没有胃肠病学家和人口密度最高的地区,在爱德华王子岛占33%(1 / 3),魁北克占32%,安大略省占25%,不列颠哥伦比亚省占7%,马尼托巴省占4%。全国只有94个TEs被确定。结论:我们发现加拿大各地肝脏特异性资源存在显著差异。鉴于患有肝病的人数不断增加,必须实施政策,解决获得专门护理的问题。
{"title":"Geographical disparities in gastroenterologists and transient elastography across Canada","authors":"Jessica Burnside, Tyler Thomas, Giada Sebastiani, Sahar Saeed","doi":"10.3138/canlivj-2023-0010","DOIUrl":"https://doi.org/10.3138/canlivj-2023-0010","url":null,"abstract":"Background: In the next decade, the incidence and prevalence of advanced liver disease are expected to increase across Canada. However, little is known about the country's resources for monitoring patients requiring specialized care. A resource assessment was conducted to evaluate regional disparities of specialists and transient elastography machines across Canada. Methods: Demographic data on licenced gastroenterologists were obtained from Scott's Medical Directory as of October 2022. The primary location of each specialist was linked to 2016 Statistics Canada to obtain the population size and density of province/territories and census division (CD). Results were summarized per 100,000 persons. CD were classified as resource scare or approaching resource scarcity. A list of transient elastography (TE) was provided by KNS Canada Inc. and summarized per 1,000,000 persons by province. Results: Eight hundred fifty-three specialists were identified. Rates of gastroenterologists per 100,000 people ranged from 0 in the territories to 2.9 in Quebec. Half the provinces had less than 2.0 gastroenterologists per 100,000 persons. Gastroenterologists were concentrated in 24% (71/293) of the CDs across Canada. We identified resource-scarce CDs as areas with no gastroenterologists and in the highest tercile of population density, which accounted for 33% (1 of 3) in Prince Edward Island, 32% in Quebec, 25% in Ontario, 7% in British Columbia, and 4% in Manitoba. Only 94 TEs were identified nationwide. Conclusion: We found significant variation in liver-specific resources across Canada. Given the increasing number of people living with liver disease, policies must be implemented to address access to specialized care.","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135728807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of a case definition to estimate the prevalence and incidence of cirrhosis in pan-Canadian primary care databases 在泛加拿大初级保健数据库中评估肝硬化患病率和发病率的病例定义的发展和验证
Pub Date : 2023-10-19 DOI: 10.3138/canlivj-2023-0002
Nabiha Faisal, Leanne Kosowan, Hasan Zafari, Farhana Zulkernine, Lisa Lix, Alyson Mahar, Harminder Singh, Eberhard Renner, Alexander Singer
Aims: To develop and validate case definitions to identify patients with cirrhosis and alcohol-related cirrhosis using primary care electronic medical records (EMRs) and to estimate cirrhosis prevalence and incidence in pan-Canadian primary care database, between 2011 and 2019. Methods: A total of 689,301 adult patients were included with ≥1 visit to a primary care provider within the Canadian Primary Care Sentinel Study Network between January 1, 2017 and December 31, 2018. Subsample of 17,440 patients was used to validate the case definitions. Sensitivity, specificity, predictive values were calculated with their 95% confidence intervals (CI) and then determined the population-level prevalence and incidence trends with the most accurate case definition. Results: The most accurate case definition included: ≥1 health condition, billing, or encounter diagnosis for International Classification of Diseases, Ninth Revision codes 571.2, 571.5, 789.59, or 571. Sensitivity (84.6; 95% CI: 83.1–86.%), specificity (99.3; 95% CI: 99.1–99.4%), positive predictive values (94.8; 95% CI: 93.9–95.7%), and negative predictive values (97.5; 95% CI: 97.3–97.7%). Application of this definition to the overall population resulted in a crude prevalence estimate of (0.46%, 95% CI: 0.45%–0.48%). Annual incidence of patients with a clinical diagnosis of cirrhosis nearly doubled between 2011 (0.05%, 95% CI: 0.04%–0.06%) and 2019 to (0.09%, 95% CI: 0.08%–0.09%). Conclusions: The EMR-based case definition accurately captured patients diagnosed with cirrhosis in primary care. Future work to characterize patients with cirrhosis and their primary care experiences can support improvements in identification and management in primary care settings.
目的:制定和验证病例定义,利用初级保健电子医疗记录(emr)识别肝硬化和酒精相关肝硬化患者,并估计2011年至2019年期间泛加拿大初级保健数据库中的肝硬化患病率和发病率。方法:在2017年1月1日至2018年12月31日期间,共有689,301名成年患者在加拿大初级保健哨点研究网络中进行了≥1次的初级保健提供者就诊。采用17440例患者的子样本来验证病例定义。计算灵敏度、特异性和预测值及其95%置信区间(CI),然后确定最准确病例定义的人群水平患病率和发病率趋势。结果:最准确的病例定义包括:≥1种健康状况、账单或遭遇诊断(《国际疾病分类》第九次修订代码571.2、571.5、789.59或571)。灵敏度(84.6;95% CI: 83.1 - 86%),特异性(99.3;95% CI: 99.1-99.4%),阳性预测值(94.8;95% CI: 93.9-95.7%),阴性预测值(97.5;95% ci: 97.3-97.7%)。将这一定义应用于总体人群,得出了粗略的患病率估计值(0.46%,95% CI: 0.45%-0.48%)。临床诊断为肝硬化的患者年发病率在2011年(0.05%,95% CI: 0.04%-0.06%)和2019年(0.09%,95% CI: 0.08%-0.09%)之间几乎翻了一番。结论:基于emr的病例定义准确地捕获了初级保健中诊断为肝硬化的患者。未来对肝硬化患者特征及其初级保健经历的研究,将有助于改善初级保健机构的识别和管理。
{"title":"Development and validation of a case definition to estimate the prevalence and incidence of cirrhosis in pan-Canadian primary care databases","authors":"Nabiha Faisal, Leanne Kosowan, Hasan Zafari, Farhana Zulkernine, Lisa Lix, Alyson Mahar, Harminder Singh, Eberhard Renner, Alexander Singer","doi":"10.3138/canlivj-2023-0002","DOIUrl":"https://doi.org/10.3138/canlivj-2023-0002","url":null,"abstract":"Aims: To develop and validate case definitions to identify patients with cirrhosis and alcohol-related cirrhosis using primary care electronic medical records (EMRs) and to estimate cirrhosis prevalence and incidence in pan-Canadian primary care database, between 2011 and 2019. Methods: A total of 689,301 adult patients were included with ≥1 visit to a primary care provider within the Canadian Primary Care Sentinel Study Network between January 1, 2017 and December 31, 2018. Subsample of 17,440 patients was used to validate the case definitions. Sensitivity, specificity, predictive values were calculated with their 95% confidence intervals (CI) and then determined the population-level prevalence and incidence trends with the most accurate case definition. Results: The most accurate case definition included: ≥1 health condition, billing, or encounter diagnosis for International Classification of Diseases, Ninth Revision codes 571.2, 571.5, 789.59, or 571. Sensitivity (84.6; 95% CI: 83.1–86.%), specificity (99.3; 95% CI: 99.1–99.4%), positive predictive values (94.8; 95% CI: 93.9–95.7%), and negative predictive values (97.5; 95% CI: 97.3–97.7%). Application of this definition to the overall population resulted in a crude prevalence estimate of (0.46%, 95% CI: 0.45%–0.48%). Annual incidence of patients with a clinical diagnosis of cirrhosis nearly doubled between 2011 (0.05%, 95% CI: 0.04%–0.06%) and 2019 to (0.09%, 95% CI: 0.08%–0.09%). Conclusions: The EMR-based case definition accurately captured patients diagnosed with cirrhosis in primary care. Future work to characterize patients with cirrhosis and their primary care experiences can support improvements in identification and management in primary care settings.","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":"162 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135728956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of different definitions of metabolic syndrome and their associations with non-alcoholic fatty liver disease: a retrospective study 代谢综合征不同定义的比较及其与非酒精性脂肪性肝病的关系:一项回顾性研究
Pub Date : 2023-10-19 DOI: 10.3138/canlivj-2023-0006
Carmen Tse, Nicholas Lisanti, Micah Grubert Van Iderstine, Julia Uhanova, Gerald Minuk, Nabiha Faisal
Background: Metabolic syndrome (MetS) is considered an important risk factor for non-alcoholic fatty liver disease (NAFLD). The aim of this study was to measure the prevalence of MetS based on six different MetS definitions and compare the performance of various definitions for identifying diabetes, hypertension, and dyslipidemia among NAFLD patients. Methods: The definitions compared were those developed by the World Health Organization (WHO), National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III), International Diabetes Federation (IDF), American Association of Clinical Endocrinologists (AACE), American Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI), and Interim Joint Statement “Harmonized” criteria. Receiver operator characteristic (ROC) curves were plotted for the six MetS definitions with NAFLD diagnosis. The diagnosis for NAFLD was established based on liver imaging or biopsy compatible with fatty liver disease. Results: A total of 500 NAFLD patients were analyzed. The mean age was 61.2 ± 13.2 years, and BMI was 32.7 ± 8.0 kg/m 2 . The most prevalent MetS component was dyslipidemia 83%, followed by hypertension 60%, obesity 61%, and diabetes 57%. The prevalence of MetS according to the WHO, NCEP/ATP-III, IDF, AACE, AHA/NHLBI, and harmonized criteria was 69%, 59%, 54%, 64%, 78%, and 79%, respectively. The highest area under the receiver operating characteristic curve for diabetes and hypertension was with the WHO definition (0.7405) and (0.8120), respectively. Conclusions: The prevalence of MetS in NAFLD patients varies according to the definitions of MetS employed. The modified WHO definition appeared to be most useful for the screening of MetS in NAFLD patients.
背景:代谢综合征(MetS)被认为是非酒精性脂肪性肝病(NAFLD)的重要危险因素。本研究的目的是基于六种不同的MetS定义来测量MetS的患病率,并比较不同定义在NAFLD患者中识别糖尿病、高血压和血脂异常的性能。方法:比较世界卫生组织(WHO)、国家胆固醇教育计划成人治疗小组III (NCEP-ATP III)、国际糖尿病联合会(IDF)、美国临床内分泌学家协会(AACE)、美国心脏协会/国家心肺血液研究所(AHA/NHLBI)和临时联合声明“协调”标准制定的定义。绘制了NAFLD诊断的6种MetS定义的受试者操作特征(ROC)曲线。NAFLD的诊断是基于与脂肪肝相容的肝脏影像学或活检。结果:共分析了500例NAFLD患者。平均年龄61.2±13.2岁,BMI 32.7±8.0 kg/ m2。最常见的代谢代谢成分是血脂异常83%,其次是高血压60%,肥胖61%,糖尿病57%。根据WHO、NCEP/ATP-III、IDF、AACE、AHA/NHLBI和协调标准,met的患病率分别为69%、59%、54%、64%、78%和79%。糖尿病和高血压患者工作特征曲线下的最高面积分别为(0.7405)和(0.8120)。结论:NAFLD患者中MetS的流行程度因MetS的定义而异。修订后的WHO定义似乎对NAFLD患者的met筛查最有用。
{"title":"Comparison of different definitions of metabolic syndrome and their associations with non-alcoholic fatty liver disease: a retrospective study","authors":"Carmen Tse, Nicholas Lisanti, Micah Grubert Van Iderstine, Julia Uhanova, Gerald Minuk, Nabiha Faisal","doi":"10.3138/canlivj-2023-0006","DOIUrl":"https://doi.org/10.3138/canlivj-2023-0006","url":null,"abstract":"Background: Metabolic syndrome (MetS) is considered an important risk factor for non-alcoholic fatty liver disease (NAFLD). The aim of this study was to measure the prevalence of MetS based on six different MetS definitions and compare the performance of various definitions for identifying diabetes, hypertension, and dyslipidemia among NAFLD patients. Methods: The definitions compared were those developed by the World Health Organization (WHO), National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III), International Diabetes Federation (IDF), American Association of Clinical Endocrinologists (AACE), American Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI), and Interim Joint Statement “Harmonized” criteria. Receiver operator characteristic (ROC) curves were plotted for the six MetS definitions with NAFLD diagnosis. The diagnosis for NAFLD was established based on liver imaging or biopsy compatible with fatty liver disease. Results: A total of 500 NAFLD patients were analyzed. The mean age was 61.2 ± 13.2 years, and BMI was 32.7 ± 8.0 kg/m 2 . The most prevalent MetS component was dyslipidemia 83%, followed by hypertension 60%, obesity 61%, and diabetes 57%. The prevalence of MetS according to the WHO, NCEP/ATP-III, IDF, AACE, AHA/NHLBI, and harmonized criteria was 69%, 59%, 54%, 64%, 78%, and 79%, respectively. The highest area under the receiver operating characteristic curve for diabetes and hypertension was with the WHO definition (0.7405) and (0.8120), respectively. Conclusions: The prevalence of MetS in NAFLD patients varies according to the definitions of MetS employed. The modified WHO definition appeared to be most useful for the screening of MetS in NAFLD patients.","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135728939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying opportunities for hepatic encephalopathy self-management: A mixed methods systematic review and synthesis. 确定肝性脑病自我管理的机会:一项混合方法的系统综述和综合。
Pub Date : 2023-07-26 eCollection Date: 2023-07-01 DOI: 10.3138/canlivj-2022-0025
Kathleen P Ismond, Jude A Spiers, Puneeta Tandon

Background: Hepatic encephalopathy (HE) in cirrhosis is an extremely challenging complication for patients and care partners. To identify potentially modifiable factors to enhance HE self-management strategies, we conducted a synthesis of quantitative and qualitative research about real-world HE behaviours, knowledge, and experiences.

Methods: Using the EPPI-Centre's mixed methods synthesis procedure, a systematic literature search in five databases was completed; methods of selected articles underwent critical appraisal followed by descriptive analysis and coded line-by-line of content. Through refutational translation, the findings from the quantitative and qualitative syntheses were juxtaposed to highlight congruencies, incongruencies, or gaps. These findings informed generation of cross-analytical themes that were transformed into action statements.

Results: The quantitative narrative review of synthesis (n = 17) generated four themes (patients had low awareness of HE and low treatment adherence rates, physicians had a non-uniform approach to non-pharmaceutical therapies). Meta-aggregation of qualitative data from six articles yielded three themes (patients and care partners had low levels of HE awareness, were unfamiliar with HE self-management, and were adherent to treatments). Comparison of findings revealed three congruencies, two gaps, and one incongruency. The combined synthesis yielded two self-management themes: universal patient-oriented cirrhosis HE education and ensuring each health care encounter systematically addresses HE to guarantee health care is continuously modified to meet their needs.

Conclusions: By drawing on elements of Bloom's Taxonomy and distributed knowledge networks, deliberate patient-oriented HE messaging at all health care encounters is greatly needed to improve health outcomes and reduce care burdens related to HE.

背景:肝硬化肝性脑病(HE)对患者和护理伙伴来说是一种极具挑战性的并发症。为了确定潜在的可改变因素以增强高等教育自我管理策略,我们对现实世界的高等教育行为、知识和经验进行了定量和定性的综合研究。方法:采用EPPI中心的混合方法综合程序,在五个数据库中进行系统的文献检索;方法对所选文章进行批判性评价,然后进行描述性分析,逐行编码内容。通过反驳翻译,将定量和定性综合的结果并置,以突出一致性、不一致性或差距。这些发现为生成交叉分析主题提供了信息,这些主题被转化为行动声明。结果:合成的定量叙述综述(n=17)产生了四个主题(患者对HE的认识低,治疗依从性低,医生对非药物治疗的方法不统一)。来自六篇文章的定性数据的荟萃分析产生了三个主题(患者和护理伙伴的HE意识水平较低,不熟悉HE自我管理,并且坚持治疗)。研究结果的比较显示了三个一致性、两个差距和一个不一致性。综合研究产生了两个自我管理主题:普遍的以患者为导向的肝硬化HE教育和确保每次医疗保健都系统地解决HE问题,以确保医疗保健不断改进以满足他们的需求。结论:通过借鉴Bloom分类法和分布式知识网络的元素,在所有医疗保健遭遇中都非常需要深思熟虑的以患者为导向的HE信息,以改善健康结果并减轻与HE相关的护理负担。
{"title":"Identifying opportunities for hepatic encephalopathy self-management: A mixed methods systematic review and synthesis.","authors":"Kathleen P Ismond,&nbsp;Jude A Spiers,&nbsp;Puneeta Tandon","doi":"10.3138/canlivj-2022-0025","DOIUrl":"10.3138/canlivj-2022-0025","url":null,"abstract":"<p><strong>Background: </strong>Hepatic encephalopathy (HE) in cirrhosis is an extremely challenging complication for patients and care partners. To identify potentially modifiable factors to enhance HE self-management strategies, we conducted a synthesis of quantitative and qualitative research about real-world HE behaviours, knowledge, and experiences.</p><p><strong>Methods: </strong>Using the EPPI-Centre's mixed methods synthesis procedure, a systematic literature search in five databases was completed; methods of selected articles underwent critical appraisal followed by descriptive analysis and coded line-by-line of content. Through refutational translation, the findings from the quantitative and qualitative syntheses were juxtaposed to highlight congruencies, incongruencies, or gaps. These findings informed generation of cross-analytical themes that were transformed into action statements.</p><p><strong>Results: </strong>The quantitative narrative review of synthesis (<i>n</i> = 17) generated four themes (patients had low awareness of HE and low treatment adherence rates, physicians had a non-uniform approach to non-pharmaceutical therapies). Meta-aggregation of qualitative data from six articles yielded three themes (patients and care partners had low levels of HE awareness, were unfamiliar with HE self-management, and were adherent to treatments). Comparison of findings revealed three congruencies, two gaps, and one incongruency. The combined synthesis yielded two self-management themes: universal patient-oriented cirrhosis HE education and ensuring each health care encounter systematically addresses HE to guarantee health care is continuously modified to meet their needs.</p><p><strong>Conclusions: </strong>By drawing on elements of Bloom's Taxonomy and distributed knowledge networks, deliberate patient-oriented HE messaging at all health care encounters is greatly needed to improve health outcomes and reduce care burdens related to HE.</p>","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":"6 2","pages":"215-233"},"PeriodicalIF":0.0,"publicationDate":"2023-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370725/pdf/canlivj-2022-0025.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10301006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Canadian hepatitis C treatment landscape: Time to turn chaos into order. 加拿大丙型肝炎治疗现状:是时候化混乱为有序了。
Pub Date : 2023-07-26 eCollection Date: 2023-07-01 DOI: 10.3138/canlivj-2023-0008
Kienan P Williams, Kate Pr Dunn, Samuel S Lee
{"title":"The Canadian hepatitis C treatment landscape: Time to turn chaos into order.","authors":"Kienan P Williams, Kate Pr Dunn, Samuel S Lee","doi":"10.3138/canlivj-2023-0008","DOIUrl":"10.3138/canlivj-2023-0008","url":null,"abstract":"","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":"6 2","pages":"187-189"},"PeriodicalIF":0.0,"publicationDate":"2023-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370726/pdf/canlivj-2023-0008.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10264279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Priority actions for elevating liver health in Canada: A call to action. 提高加拿大肝脏健康的优先行动:行动呼吁。
Pub Date : 2023-07-26 eCollection Date: 2023-07-01 DOI: 10.3138/canlivj-2022-0041
Mayur Brahmania, Mia J Biondi, Supriya Joshi, Elizabeth Lee, Hsiao-Ming Jung, Mohit Kehar

Chronic liver disease (CLD) has become a silent epidemic in our country and has resulted in significant physical, psychosocial, and financial burden. Although other international liver associations have published frameworks for the principal actions required to improve liver health across health systems, Canada does not have a strategy to address the growing concerns of CLD. Thus, a multidisciplinary group of care providers involved in CLD management in Canada gathered to review the current burden of disease, gaps in management, and key opportunities for improving the identification and management of people at risk of developing progressive CLD.

慢性肝病(CLD)在我国已成为一种无声的流行病,并造成了巨大的身体、心理和经济负担。尽管其他国际肝脏协会已经公布了改善整个卫生系统肝脏健康所需的主要行动框架,但加拿大没有解决CLD日益严重的问题的战略。因此,一个由加拿大CLD管理人员组成的多学科护理小组聚集在一起,审查当前的疾病负担、管理差距以及改善对有发展为渐进性CLD风险的人群的识别和管理的关键机会。
{"title":"Priority actions for elevating liver health in Canada: A call to action.","authors":"Mayur Brahmania,&nbsp;Mia J Biondi,&nbsp;Supriya Joshi,&nbsp;Elizabeth Lee,&nbsp;Hsiao-Ming Jung,&nbsp;Mohit Kehar","doi":"10.3138/canlivj-2022-0041","DOIUrl":"10.3138/canlivj-2022-0041","url":null,"abstract":"<p><p>Chronic liver disease (CLD) has become a silent epidemic in our country and has resulted in significant physical, psychosocial, and financial burden. Although other international liver associations have published frameworks for the principal actions required to improve liver health across health systems, Canada does not have a strategy to address the growing concerns of CLD. Thus, a multidisciplinary group of care providers involved in CLD management in Canada gathered to review the current burden of disease, gaps in management, and key opportunities for improving the identification and management of people at risk of developing progressive CLD.</p>","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":"6 2","pages":"283-290"},"PeriodicalIF":0.0,"publicationDate":"2023-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370728/pdf/canlivj-2022-0041.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10264277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Province-to-province variability in hepatitis C testing, care, and treatment across Canada. 加拿大丙型肝炎检测、护理和治疗的省际差异
Pub Date : 2023-07-01 DOI: 10.3138/canlivj-2022-0029
Erin Mandel, Kate Underwood, Chelsea Masterman, Robert A Kozak, Cheryl H Dale, Melinda Hassall, Camelia Capraru, Hemant Shah, Harry LA Janssen, Jordan J Feld, Mia J Biondi

Background: Few countries have implemented the necessary policy changes to reduce the number of steps in the cascade of care to achieve hepatitis C virus (HCV) elimination, including Canada. The aim of this study was to describe and compare legislation, scope of practice, and policy as it relates to the provision of HCV care in each province.

Methods: We reviewed grey literature and regulatory and legislative documents which affect various aspects of the HCV cascade of care. Findings were verified by content experts.

Results: HCV RNA reflex testing ensures those that are antibody positive get an HCV RNA test; however only 80% of provinces have reflex test. Point-of-care antibody testing can be offered in most community non-health care settings, yet many types of health care providers are unable to do this independently. Following a positive test, it may not be feasible to complete venipuncture; however only a single province processes HCV RNA dried blood spot cards. In many provinces, training and verification are required for novice prescribers, and in some provinces prescribing continues to be restricted to specialists. Only a single province has task-shifted treatment to a non-physician non-nurse practitioner model, where pharmacists can prescribe treatment. Finally, 80% of provinces require authorization forms, and 30% require proof of investigations for treatment.

Conclusions: No single province is optimizing the use of diagnostic tools and task shifting and decreasing paperwork to expedite treatment initiation. Collaboration between provinces is needed to streamline practice, update policy, and promote equity in HCV diagnosis, care, and treatment.

背景:包括加拿大在内,很少有国家实施了必要的政策改革,以减少实现消除丙型肝炎病毒(HCV)的级联治疗步骤。本研究的目的是描述和比较各省与提供HCV治疗有关的立法、实践范围和政策。方法:我们回顾了灰色文献以及影响HCV级联治疗各个方面的监管和立法文件。调查结果得到了内容专家的验证。结果:HCV RNA反射检测确保抗体阳性的患者得到HCV RNA检测;然而,只有80%的省份有反射测试。大多数社区非卫生保健机构都可以提供即时抗体检测,但许多类型的卫生保健提供者无法独立完成这项工作。阳性检测后,可能无法完成静脉穿刺;然而,只有一个省份处理HCV RNA干血卡片。在许多省份,需要对新手开处方者进行培训和核查,在一些省份,处方仍然仅限于专科医生。只有一个省份将治疗任务转移到非医师非护士执业模式,药剂师可以开处方治疗。最后,80%的省份需要授权表格,30%的省份需要治疗调查证明。结论:没有一个省份正在优化诊断工具的使用,任务转移和减少文书工作,以加快治疗启动。各省之间需要合作,以简化实践,更新政策,促进丙型肝炎病毒诊断、护理和治疗的公平性。
{"title":"Province-to-province variability in hepatitis C testing, care, and treatment across Canada.","authors":"Erin Mandel,&nbsp;Kate Underwood,&nbsp;Chelsea Masterman,&nbsp;Robert A Kozak,&nbsp;Cheryl H Dale,&nbsp;Melinda Hassall,&nbsp;Camelia Capraru,&nbsp;Hemant Shah,&nbsp;Harry LA Janssen,&nbsp;Jordan J Feld,&nbsp;Mia J Biondi","doi":"10.3138/canlivj-2022-0029","DOIUrl":"https://doi.org/10.3138/canlivj-2022-0029","url":null,"abstract":"<p><strong>Background: </strong>Few countries have implemented the necessary policy changes to reduce the number of steps in the cascade of care to achieve hepatitis C virus (HCV) elimination, including Canada. The aim of this study was to describe and compare legislation, scope of practice, and policy as it relates to the provision of HCV care in each province.</p><p><strong>Methods: </strong>We reviewed grey literature and regulatory and legislative documents which affect various aspects of the HCV cascade of care. Findings were verified by content experts.</p><p><strong>Results: </strong>HCV RNA reflex testing ensures those that are antibody positive get an HCV RNA test; however only 80% of provinces have reflex test. Point-of-care antibody testing can be offered in most community non-health care settings, yet many types of health care providers are unable to do this independently. Following a positive test, it may not be feasible to complete venipuncture; however only a single province processes HCV RNA dried blood spot cards. In many provinces, training and verification are required for novice prescribers, and in some provinces prescribing continues to be restricted to specialists. Only a single province has task-shifted treatment to a non-physician non-nurse practitioner model, where pharmacists can prescribe treatment. Finally, 80% of provinces require authorization forms, and 30% require proof of investigations for treatment.</p><p><strong>Conclusions: </strong>No single province is optimizing the use of diagnostic tools and task shifting and decreasing paperwork to expedite treatment initiation. Collaboration between provinces is needed to streamline practice, update policy, and promote equity in HCV diagnosis, care, and treatment.</p>","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":"6 2","pages":"234-248"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370727/pdf/canlivj-2022-0029.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9887661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Review of liver transplantation candidacy and outcomes among patients who use cannabis: Is it time for a change in policy? 大麻使用者肝移植候选性和结果的回顾:是时候改变政策了吗?
Pub Date : 2023-07-01 DOI: 10.3138/canlivj-2022-0038
Man Ting Kristina Yau, Trana Hussaini, Eric M Yoshida

Background: Recreational cannabis was legalized in Canada in 2018. A controversial contraindication for liver transplantation is cannabis. There is currently no consensus regarding cannabis use in liver transplant candidates. We aim to investigate liver transplantation candidacy and outcomes among cannabis users.

Methods: English peer-reviewed studies on PubMed and Google Scholar were searched on September 9, 2022, using keywords including "cannabis," "liver transplantation," and their synonyms. Titles and abstracts were screened, followed by full texts. Reference lists were reviewed. Studies that investigated liver transplantation candidacy and outcomes among cannabis users were included.

Results: The proportion of patients listed for liver transplantation was significantly less among cannabis users than among non-users. Time to listing was longer for cannabis users than non-users. The incidence of delisting was similar. There is an inconsistency between transplant centres regarding transplantation candidacy for cannabis users. While only 14% of Canadian centres had a policy in place and preferred candidates to abstain or decrease cannabis use before transplantation, a third of Canadian centres rejected cannabis users. Observational studies failed to demonstrate significant differences in patient survival between pre-transplantation cannabis users and non-users. However, self-reported mental health ratings were worse in post-transplantation cannabis users than in non-users and former users.

Conclusions: Current observational data do not support a link between cannabis use and poor patient survival post-transplantation. However, high-quality prospective studies are needed to better elucidate the impact of cannabis use on liver transplantation outcomes. Liver transplant candidacy should be evaluated through a multidisciplinary and comprehensive approach considering all relevant psychosocial factors.

背景:2018年,加拿大将娱乐性大麻合法化。肝移植的一个有争议的禁忌症是大麻。目前对肝移植候选人使用大麻尚无共识。我们的目的是调查大麻使用者的肝移植候选性和结果。方法:于2022年9月9日检索PubMed和Google Scholar上的英文同行评议研究,关键词包括“大麻”、“肝移植”及其同义词。先筛选标题和摘要,然后是全文。审查了参考文献清单。包括调查大麻使用者肝移植候选性和结果的研究。结果:大麻使用者中肝移植患者的比例明显低于非大麻使用者。大麻使用者的上市时间比非使用者要长。退市的发生率相似。移植中心之间关于大麻使用者的移植候选性存在不一致。虽然只有14%的加拿大中心制定了政策,并倾向于候选人在移植前放弃或减少使用大麻,但三分之一的加拿大中心拒绝大麻使用者。观察性研究未能证明移植前大麻使用者和非使用者在患者生存方面存在显著差异。然而,移植后大麻使用者自我报告的心理健康评级比非使用者和前使用者更差。结论:目前的观察数据不支持大麻使用与移植后患者生存差之间的联系。然而,需要高质量的前瞻性研究来更好地阐明大麻使用对肝移植结果的影响。考虑到所有相关的社会心理因素,应该通过多学科和综合的方法来评估肝移植的候选性。
{"title":"Review of liver transplantation candidacy and outcomes among patients who use cannabis: Is it time for a change in policy?","authors":"Man Ting Kristina Yau,&nbsp;Trana Hussaini,&nbsp;Eric M Yoshida","doi":"10.3138/canlivj-2022-0038","DOIUrl":"https://doi.org/10.3138/canlivj-2022-0038","url":null,"abstract":"<p><strong>Background: </strong>Recreational cannabis was legalized in Canada in 2018. A controversial contraindication for liver transplantation is cannabis. There is currently no consensus regarding cannabis use in liver transplant candidates. We aim to investigate liver transplantation candidacy and outcomes among cannabis users.</p><p><strong>Methods: </strong>English peer-reviewed studies on PubMed and Google Scholar were searched on September 9, 2022, using keywords including \"cannabis,\" \"liver transplantation,\" and their synonyms. Titles and abstracts were screened, followed by full texts. Reference lists were reviewed. Studies that investigated liver transplantation candidacy and outcomes among cannabis users were included.</p><p><strong>Results: </strong>The proportion of patients listed for liver transplantation was significantly less among cannabis users than among non-users. Time to listing was longer for cannabis users than non-users. The incidence of delisting was similar. There is an inconsistency between transplant centres regarding transplantation candidacy for cannabis users. While only 14% of Canadian centres had a policy in place and preferred candidates to abstain or decrease cannabis use before transplantation, a third of Canadian centres rejected cannabis users. Observational studies failed to demonstrate significant differences in patient survival between pre-transplantation cannabis users and non-users. However, self-reported mental health ratings were worse in post-transplantation cannabis users than in non-users and former users.</p><p><strong>Conclusions: </strong>Current observational data do not support a link between cannabis use and poor patient survival post-transplantation. However, high-quality prospective studies are needed to better elucidate the impact of cannabis use on liver transplantation outcomes. Liver transplant candidacy should be evaluated through a multidisciplinary and comprehensive approach considering all relevant psychosocial factors.</p>","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":"6 2","pages":"269-277"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370722/pdf/canlivj-2022-0038.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9887662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Canadian liver journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1